LORI BRADY: Open Payments
NPI 1568958429 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 49 payments from 14 companies in 2025. Trend: 2023 $738 · 2024 $764 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $274 |
| E.R. Squibb & Sons, L.L.C. | 10 | $141 |
| SCPHARMACEUTICALS INC. | 5 | $93 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $83 |
| Novo Nordisk Inc | 3 | $70 |
| Merck Sharp & Dohme LLC | 3 | $56 |
| Boston Scientific Corporation | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| PFIZER INC. | 2 | $30 |
| Amgen Inc. | 1 | $21 |
Products named: LEQVIO, CAMZYOS, FUROSCIX, LifeVest, ENTRESTO, VERQUVO, Wegovy, JARDIANCE.
Industry payments across GA — which companies pay providers there.
